Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Aegis Group’s Carat will lose its estimated $250 million planning and buying assignment for Pfizer Consumer Health Care once Johnson & Johnson closes on its acquisition of the Pfizer unit by year’s end, a J&J rep confirmed today.
After the deal is completed, “Interpublic Group and OMD will handle planning and buying in North America for the J&J and Pfizer brands,” the rep said.
IPG’s Universal McCann currently handles J&J’s North American media chores, while Omnicom Group’s OMD works for the company mainly in the rapidly expanding market of China.
It
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in